-
From nuchal translucency to intracranial translucency: towards the early detection of spina bifida.
Chaoui R, Nicolaides KH.
Ultrasound Obstet Gynecol 2010;35:133-8. -
Prospective validation of first-trimester combined screening for trisomy 21.
Kagan KO, Etchegaray A, Zhou Y, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2009;34:14-8. -
Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21.
Kagan KO, Wright D, Etchegaray A, Zhou Y, Nicolaides KH.
Ultrasound Obstet Gynecol 2009;33:657-64. -
Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11-13-week scan.
Chaoui R, Benoit B, Mitkowska-Wozniak H, Heling KS, Nicolaides KH.
Ultrasound Obstet Gynecol 2009;34:249-52. -
Maternal arterial stiffness in pregnancies affected by Type 1 diabetes mellitus.
Anderson JM, Savvidou MD, Kaihura C, McEniery CM, Nicolaides KH.
Diabet Med 2009;26:1135-40. -
Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers.
Spencer K, Kagan KO, Nicolaides KH.
Prenat Diagn 2008;28:49-52. -
Prenasal thickness in trisomy-21 fetuses at 16-24 weeks of gestation.
Persico N, Borenstein M, Molina F, Azumendi G, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:751-4. -
Frontomaxillary facial angle in trisomy 21 fetuses at 16-24 weeks of gestation.
Molina F, Persico N, Borenstein M, Sonek J, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;31:384-7. -
Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;31:618-24. -
First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;31:493-50. -
Choroid plexus cyst, intracardiac echogenic focus, hyperechogenic bowel and hydronephrosis in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.
Dagklis T, Plasencia W, Maiz N, Duarte L, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;31:132-5. -
Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.
Borenstein M, Persico N, Kagan KO, Gazzoni A, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:5-11. -
Frontomaxillary facial angles in screening for trisomy 21 at 14-23 weeks gestation.
Sonek J, Borenstein M, Downing C, McKenna D, Neiger R, Croom C, Genrich T, Nicolaides KH.
Am J Obstet Gynecol 2007;197:160. -
Frontomaxillary facial angle in fetuses with trisomy 21 at 11+0-13+6 weeks.
Sonek J, Borenstein M, Dagklis T, Persico N, Nicolaides KH.
Am J Obstet Gynecol 2007;196:271. -
First-trimester screening for trisomy 21 using nuchal translucency and nasal bone evaluations in a selected and an unselected population.
Sonek J, Cicero S, Nicolaides K.
Am J Obstet Gynecol 2007;196:19. -
Some thoughts on the true value of ultrasound.
Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:671-4. -
Dilemmas in the management of twins discordant for anencephaly diagnosed at 11 + 0 to 13 + 6 weeks of gestation.
Vandecruys H, Avgidou K, Surerus E, Flack N, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;28:653-8. -
Nasal bone assessment in prenatal screening for trisomy 21.
Sonek JD, Cicero S, Neiger R, Nicolaides KH.
Am J Obstet Gynecol 2006;195:1219-30. -
Metopic suture in fetuses with trisomy 21 at 11 + 0 to 13 + 6 weeks of gestation.
Faro C, Wegrzyn P, Benoit B, Chaoui R, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:286-9. -
Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:151-5.